Back to Journals » Clinical Ophthalmology » Volume 11

Regarding optical coherence tomography grading of ischemia in central retinal venous occlusion

Authors Tripathy K

Received 10 January 2017

Accepted for publication 17 January 2017

Published 22 February 2017 Volume 2017:11 Pages 409—410

DOI https://doi.org/10.2147/OPTH.S132101

Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser

Koushik Tripathy

Department of Vitreoretina and Uvea, ICARE Eye Hospital & Postgraduate Institute, Noida, Uttar Pradesh, India

The author read with interest the article by Browning et al.1 The author humbly wants to discuss a few facts.
1. The article1 discusses grading of retinal ischemia based on optical coherence tomography features in central retinal venous occlusion. As coexisting central retinal arterial occlusion or cilioretinal arterial occlusion may also cause inner retinal hyper-reflectivity, exclusion of such cases is an important consideration before implicating central retinal venous occlusion for the ischemia. Extensive intraretinal hemorrhages are other important hindrances to the evaluation of the perfusion status of the retina using both fluorescein angiogram and optical coherence tomography.
2. It would be interesting to know the gonioscopic findings, especially neovascularization of the anterior chamber angle if it was performed at presentation and during the follow-ups.
3. The manuscript documented that the incidence of anterior segment neovascularization at 1 year was 8.9% in severe ischemia group.1 The incidence of anterior segment neovascularization in perfused groups was higher (15.4% and 17.6% for mild and moderate ischemia, respectively). Although the sample size was low, such findings are contrary to the literature2 and require further discussion.
 
Authors' reply

David J Browning, Omar S Punjabi, Chong Lee

Department of Ophthalmology, Charlotte Eye, Ear, Nose and Throat Associates, P.A., Charlotte, NC, USA
 
We thank Dr Tripathy for his interest in our article and would respond to his above-mentioned points.
1. We agree that excluding eyes with cilioretinal artery and central retinal artery occlusions is necessary to be able to attribute inner retinal reflectivity changes to central retinal vein occlusion. Cilioretinal artery occlusion is associated with a band of ischemic retinal whitening and central retinal artery occlusion more generalized posterior-pole ischemic whitening. Neither was present in any of our patients. The changes in inner retinal reflectivity were present without visible whitening.
The confounding effects of intraretinal hemorrhage were recognized and accounted for as found in the following sentence in “Methods” section: “When there was concomitant intraretinal hemorrhage, the grading was done based on a zone without intraretinal hemorrhage if one was present, but if intraretinal hemorrhage was confluent, the inner retina was hyperreflective and delineation of layers was obscured by the hemorrhage, such cases were graded as severe ischemia”.
2. This was a retrospective study drawn from two retina specialists (DJB and OSP). There was no standardization about when gonioscopy was performed. Therefore, the development of anterior segment neovascularization (ASNV) may have been underestimated relative to a figure derived from a systematic prospective study in which gonioscopy would be uniformly performed before pupillary dilation.
3. The incidence of ASNV recorded in Table 2 of the manuscript was confounded by the frequent injection of antivascular endothelial growth factor drugs for macular edema in all three groups. As we wrote in the “Discussion” section: “The frequent injection of anti-VEGF drugs not only treated the macular edema but also probably masked any underlying associations of ASNV and NVG with baseline ischemia”.

View the original paper by Browning et al.



Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author: